MAP2K3 antibody (AA 187-191)
Quick Overview for MAP2K3 antibody (AA 187-191) (ABIN5689473)
Target
See all MAP2K3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 187-191
-
Specificity
- This antibody detects endogenous level of total MKK3 protein.
-
Purification
- Antibodies were purified by affinity-chromatography using epitope-specific peptide.
-
Immunogen
- MKK3 (Ab-189) antibody was raised against a peptide sequence around aa.187~191 (V-D-S-V-A) derived from Human MKK3.
-
-
-
-
Application Notes
- Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store antibody at -20°C for up to one year.
-
-
- MAP2K3 (Mitogen-Activated Protein Kinase Kinase 3 (MAP2K3))
-
Alternative Name
- MKK3
-
Background
- MEK3 belongs to MAPKK family. This kinase is activated by mitogenic and environmental stress, and participates in the MAPK-mediated signaling cascade. It phosphorylates and thus activates p38. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of Ras oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of p38, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis.
-
Molecular Weight
- 40 kDa
-
Gene ID
- 5606
-
NCBI Accession
- NP_002747
-
UniProt
- P46734
-
Pathways
- MAPK Signaling, TLR Signaling, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagy, Signaling Events mediated by VEGFR1 and VEGFR2
Target
-